LUMO
Corporate Presentation- https://investors.lumos-pharma.com/static-files/20c57f3b-0d02-46c0-8b64-0bd3f54a07de
https://lumos-pharma.com/our-pipeline/lum-201/#LUM201PGHD
https://investors.lumos-pharma.com/news-releases/news-release-details/lumos-pharma-reports-second-quarter-2024-financial-results-and

Press Release
https://ir.skyebioscience.com/news-events/press-releases/detail/205/skye-bioscience-launches-phase-2-cbeyond-clinical-trial-of
https://ir.skyebioscience.com/news-events/press-releases/detail/206/skye-announces-inducement-grant-under-nasdaq-listing-rule
https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-reaches-agreement-dismiss-sunosir
https://ir.achievelifesciences.com/news-events/press-releases/detail/206/achieve-life-sciences-announces-changes-in-executive

